Obesity

© GettyImages/aquaArts studio

Alnylam has obesity gene target in its sights

By Jane Byrne

Cambridge, Massachusetts based, Alnylam Pharmaceuticals, along with collaborators, has identified mutations in the INHBE gene linked with protection against abdominal obesity.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers